Latest news
Jennifer Taubert announces retirement from J&J; Takeda’s global TYK2 leader exits - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 11:00:00 GMTTakeda (TAK) insider Nicola Greenway plans sale of 34,603 ADSs - Stock TitanStock Titan · Thu, 06 Aug 2026 21:17:47 GMTTakeda Achieves Major Milestone With Holistic Narcolepsy Drug Approval - BenzingaBenzinga · Thu, 06 Aug 2026 15:16:02 GMTTakeda (NYSE: TAK) gets FDA OK for ORZEYFUL narcolepsy therapy - Stock TitanStock Titan · Thu, 06 Aug 2026 10:05:55 GMTTakeda Says Rebates, Subsidies Cut $885M IBS Drug Verdict - Law360Law360 · Wed, 05 Aug 2026 23:55:00 GMTUS FDA approves Takeda's sleep disorder pill - ReutersReuters · Wed, 05 Aug 2026 22:48:03 GMTThe logo of Japanese Takeda Pharmaceutical Co is seen at an office building in Glattbrugg - The Lufkin Daily NewsThe Lufkin Daily News · Wed, 05 Aug 2026 22:47:49 GMTU.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1 - Business WireBusiness Wire · Wed, 05 Aug 2026 22:10:00 GMT